FDA Approved: XPHOZAH 10 MG — Original Application (Ardelyx, Inc.)

View source ↗

Summary

FDA approved XPHOZAH (tenapanor) from Ardelyx in its original NDA for the treatment of hyperphosphatemia in adults with chronic kidney disease on dialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Hyperphosphatemia

Drugs mentioned

• XPHOZAH (tenapanor)

Snippet

ORIG AP for XPHOZAH 10 MG (TENAPANOR)